Article
BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights.
International journal of molecular sciences - 28 Oct 2019
Caputo Francesco, Santini Chiara, Bardasi Camilla, Cerma Krisida, Casadei-Gardini Andrea, Spallanzani Andrea, Andrikou Kalliopi, Cascinu Stefano, Gelsomino Fabio
Abstract excerpt
Colorectal cancer (CRC) is one of the leading causes of mortality and morbidity in the world. It is a heterogeneous disease, which can be classified into different subtypes, characterized by specific molecular and morphological alterations. In this context, BRAF mutations are found in about 10% of CRC patients and define a particular subtype, characterized by a dismal prognosis, with a median survival of less...
Topics
- Antineoplastic Combined Chemotherapy Protocols
- Bevacizumab
- Colorectal Neoplasms
- Drug Resistance, Neoplasm
- Female
- Humans
- MAP Kinase Signaling System
- Male
- Melanoma
- Mutation
